Startups channel feed

Aeov­ian Phar­ma­ceu­ti­cals brings in $37 mil­lion in mTOR play

6 years ago
Financing

San Fran­cis­co biotech has its heart in heart fail­ure — and $92M in the bank

6 years ago
Cell/Gene Tx

ARC-T? Al­ter­na­tive CAR-T start­up bags $85M for clin­i­cal quest to redi­rect 'blind hunter' T cells

6 years ago
Cell/Gene Tx

Deer­field bets on New York City, blue­prints $635M biotech hub in mid­town Man­hat­tan

6 years ago

Meis­sa ob­tains $30M Se­ries A from Morn­ing­side to test syn­thet­ic bi­ol­o­gy ap­proach to 'elu­sive' RSV vac­cines

6 years ago
Financing

Boehringer In­gel­heim backs Max Planck spin­out in tak­ing a shot at tough class of can­cer tar­gets

6 years ago
Financing

Start­up EPM launch­es, high off cannabi­noid acid in­no­va­tion

6 years ago

New Flag­ship biotech wants to un­leash your genome

6 years ago

Jeff Kindler's Cen­trex­ion re­news bid to make pub­lic de­but

6 years ago
Financing

'A fourth rev­o­lu­tion in can­cer ther­a­pies': ARCH-backed Bound­less Bio flash­es big check, makes big­ger promis­es in de­but

6 years ago
Financing

Biotech boards bur­dened: Bridg­ing the suc­cess gap

6 years ago
Financing
Biotech Voices

Pre­clin­i­cal can­cer biotech IGM Bio­sciences sets stage for up­sized $175M IPO

6 years ago
Financing

Benev­o­len­tAI's lat­est fi­nanc­ing could halve its $2B val­u­a­tion — and that has Wood­ford watch­ers wor­ried

6 years ago
Financing
AI

Star founders, in­ves­ti­ga­tors hud­dle around new Boston ac­cel­er­a­tor spot­light­ing young en­tre­pre­neurs

6 years ago

Roche vet Jean-Jacques Ga­raud woos in­ter­na­tion­al be­liev­ers in his French star­tup's take on sep­tic shock

6 years ago
Financing

Strug­gling poo-test­ing start­up uBio­me files for bank­rupt­cy, months af­ter FBI kicks off in­ves­ti­ga­tion

6 years ago
FDA+

Ver­sant-backed pre­ci­sion on­col­o­gy start­up Re­pare Ther­a­peu­tics scores $82M+ in lat­est round

6 years ago
Financing

Nkar­ta maps out clin­i­cal, man­u­fac­tur­ing plans for CAR-NK fol­low­ing $114M round led by Sam­sara

6 years ago
Financing
Cell/Gene Tx

RA Cap­i­tal-backed cell ther­a­py play­er in the neoanti­gen game grabs a $121M megaround to fund first hu­man stud­ies

6 years ago
Financing

Ver­sant-backed Chi­nook gets a $65M launch round for its dis­cov­ery quest in a resur­gent kid­ney field

6 years ago
Discovery

Finch grabs a $53M round de­signed to take their ‘break­through’ mi­cro­bio­me treat­ment through a po­ten­tial­ly piv­otal tri­al

6 years ago
FDA+

Johns Hop­kins sci­en­tists raise $137M megaround for a trio of spin­outs look­ing to tack­le Alzheimer’s, Parkin­son’s and fi­bro­sis

6 years ago
Financing

Biotech tar­get­ing rare heart mu­ta­tion with gene ther­a­py scores $11M in Se­ries A haul

6 years ago
Financing
R&D

IBD start­up Lan­dos lands $60M Se­ries B in first test case of Chris Garabe­di­an's lean and mean mod­el at Xon­toge­ny

6 years ago
Financing
First page Previous page 56575859606162 Next page Last page
A service from the Financial Times